The corona pandemic continues to pose a global threat: To date, it has been possible to vaccinate only a small fraction of the total population. On top of that, there is acute danger from mutations of this virus. Against this backdrop, the DG-Nika AG research team has developed a solution for a new approach to protecting the population from serious illness: a pocket inhaler containing the active ingredient 2-DG (2-Deoxy-D-glucose). The DEGEGLUXID® pocket inhaler is effective both as prophylaxis and as therapy. The SARS-CoV-2 virus from the corona family is transmitted via the airways. The virus establishes itself in the...